Immune-Based Biomarkers as Predictors of Mortality in ECMO Therapy for Severe COVID-19 ARDS: Insights from a Retrospective Study
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms27010390 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Rosalia Busà und 20 weiteren Autor:innen. Beteiligte Einrichtung: IRCCS ISMETT, 90127 Palermo, Italy. Hauptthemen laut MEDLINE: Extracorporeal Membrane Oxygenation, COVID-19, Respiratory Distress Syndrome. Die Arbeit nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: EU funding within the NextGenerationEU-MUR -National Recovery and Resilience Plan, Mission 4, Component 2 Investment 1.3 - Extended Partnership initiative on E…, Italian Ministry of Health, Italy, EU.
Abstract (Originalsprache)
Extracorporeal membrane oxygenation (ECMO) is a vital intervention for patients with severe respiratory failure, particularly in unresponsive acute respiratory distress syndrome (ARDS) cases. However, patient selection for ECMO remains a significant challenge. This study aims to identify novel immune-based biomarkers to improve eligibility assessment and predict outcomes in critically ill COVID-19 patients undergoing ECMO. This monocentric observational retrospective cohort study included 80 patients with severe COVID-19-related pneumonia who required ECMO support due to unresponsive ARDS. The patients were admitted to the intensive care unit (ICU) of IRCCS-ISMETT Hospital between September 2020 and April 2021, before the availability of COVID-19 vaccines. All patients were infected with the original SARS-CoV-2 Wuhan strain. Using machine learning approaches, the study analyzed clinical and laboratory data, cytokine levels, RNA sequencing (RNA-seq), and immune cell profiles collected within two days of hospitalization. The analysis identified a 5.56-fold increased mortality risk in patients presenting with a combination of immune factors: a T cell exhaustion profile, low interferon-alpha (IFNα) levels, and high calprotectin levels. These immune markers were strongly associated with poorer outcomes in patients undergoing ECMO. Our findings highlight the critical role of immune profiling in ECMO patient selection and outcome prediction. Incorporating immune-based biomarkers into clinical assessments may enhance the evaluation of ECMO eligibility and guide treatment decisions, ultimately improving patient outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- IRCCS ISMETT, 90127 Palermo, Italy.
- Department of Engineering, University of Palermo, 90128 Palermo, Italy.
- Ri.MED Foundation, 90133 Palermo, Italy.
- Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties, University of Palermo, 90127 Palermo, Italy.
- Department of Biomedicine, Neuroscience and Advanced Diagnostic Diagnostic (BIND), University of Palermo, 90133 Palermo, Italy.
ORCID-Profile: Rosalia Busà, Alessia Gallo, Vitale Miceli, Salvatore Castelbuono, Giandomenico Amico, Claudia Carcione, Giovanna Russelli, Nicola Cuscino, Monica Miele, Francesca Timoneri, Mariangela Di Bella, Giovanni Zito, Ester Badami, Anna Maria Corsale, Mojtaba Shekarkar Azgomi, Pier Giulio Conaldi, Cirino Botta, Matteo Bulati
Förderung
- EU funding within the NextGenerationEU-MUR -National Recovery and Resilience Plan, Mission 4, Component 2 Investment 1.3 - Extended Partnership initiative on E…
- Italian Ministry of Health, Italy
- EU
- Italian Ministry of Health
- Ricerca Corrente, IRCCS ISMETT
Zitieren
APA
Busà, R., Panarello, G., Gallo, A., Miceli, V., Castelbuono, S., Sorrentino, M. C., Amico, G., Carcione, C., Russelli, G., Cuscino, N., Miele, M., Timoneri, F., Di Bella, M., Zito, G., Barbera, F., Badami, E., Corsale, A. M., Shekarkar Azgomi, M., Conaldi, P. G., …, & Bulati, M. (2025). Immune-Based Biomarkers as Predictors of Mortality in ECMO Therapy for Severe COVID-19 ARDS: Insights from a Retrospective Study. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27010390
Vancouver
Busà R, Panarello G, Gallo A, Miceli V, Castelbuono S, Sorrentino MC, et al. Immune-Based Biomarkers as Predictors of Mortality in ECMO Therapy for Severe COVID-19 ARDS: Insights from a Retrospective Study. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms27010390
BibTeX
@article{Bus2025,
author = {Busà, Rosalia and Panarello, Giovanna and Gallo, Alessia and Miceli, Vitale and Castelbuono, Salvatore and Sorrentino, Maria Concetta and Amico, Giandomenico and Carcione, Claudia and Russelli, Giovanna and Cuscino, Nicola and Miele, Monica and Timoneri, Francesca and Di Bella, Mariangela and Zito, Giovanni and Barbera, Floriana and Badami, Ester and Corsale, Anna Maria and Shekarkar Azgomi, Mojtaba and Conaldi, Pier Giulio and Botta, Cirino and Bulati, Matteo},
title = {Immune-Based Biomarkers as Predictors of Mortality in ECMO Therapy for Severe COVID-19 ARDS: Insights from a Retrospective Study},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms27010390}
}
EUVIMED